Basel Medical (BMGL) Debt to Equity (2024 - 2025)

Basel Medical's (BMGL) quarterly Debt to Equity came in at $0.93 in Q2 2025, up 143.91% year-on-year from $0.38 in Q2 2024, and up 143.91% quarter-over-quarter from $0.38 in Q2 2024.

Basel Medical (BMGL) Debt to Equity (2024 - 2025) Analysis & Trends

Basel Medical has disclosed Debt to Equity across 2 years of filings, most recently posting $0.93 for Q2 2025.

  • Debt to Equity for Q2 2025 came in at $0.93, up 143.91% year-over-year; the trailing twelve-month figure through Jun 2025 was $0.93 (up 143.91% YoY), and the FY2025 annual result was $0.91, up 137.93% from the prior year.
  • Debt to Equity came in at $0.93 for Q2 2025 at Basel Medical, up from $0.38 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.93 in Q2 2025 to a low of $0.38 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 HCA Healthcare 83.85 Bn 86.23 Bn 16.26 Bn -16.13
2 Tenet Healthcare 14.98 Bn 14.15 Bn 4.41 Bn 2.74
3 Davita 13.99 Bn 14.84 Bn 1.07 Bn -22.31
4 Encompass Health 9.72 Bn 10.34 Bn 1.34 Bn 0.78
5 Ensign 8.90 Bn 8.31 Bn 293.37 Mn 0.06
6 Universal Health Services 8.59 Bn 8.55 Bn 3.21 Bn 0.63
7 Fresenius Medical Care AG 7.67 Bn 5.29 Bn -4.26 Bn 0.51
8 Chemed 5.97 Bn 5.96 Bn 215.76 Mn 0.11
9 Pacs 5.74 Bn 5.50 Bn 345.96 Mn 0.05
10 Basel Medical 8.86 Mn 6.52 Mn - 0.93

Historic Data

Download Data
DateValue
Jun 30, 2025 0.93
Jun 30, 2024 0.38